Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioma × Drug Therapy × Clear all

Phase

Phase NA 2 Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 11 Neoplasms 9 Pancreatic Neoplasms 7 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Lung Neoplasms 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Glioblastoma 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Head and Neck Neoplasms 4 Central Nervous System Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Astrocytoma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Mesothelioma, Malignant 2 Kidney Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2

Interventions

Temozolomide 39 Radiotherapy 13 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Surgical Procedures, Operative 7 Irinotecan 7 Radiation 6 Carboplatin 6 ribociclib 5 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Imiquimod 5 Flucytosine 5 Filgrastim 5 Erlotinib Hydrochloride 5 Carmustine 5 Aminolevulinic Acid 5 vandetanib 4 sargramostim 4 Topotecan 4 O(6)-benzylguanine 4 Imatinib Mesylate 4 IL13-PE38 4 Etoposide 4 Cyclophosphamide 4 Craniotomy 4 vocimagene amiretrorepvec 3 lentiviral minigene vaccine of COVID-19 coronavirus 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03739411 2024-11-19

Hyperpolarized Imaging in Diagnosing Participants With Glioma

University of California, San Francisco

Phase 1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡